This study looks at how well a new medicine called AR882 works in helping people with gout, a condition where painful crystals form in joints. The study checks how well AR882 lowers serum uric acid (a substance in the blood that causes gout) and its safety. Participants will take either AR882 or a placebo (a fake pill) for 12 months.

• The study lasts for 12 months, so participants need to commit for one year.
• Regular visits to the doctor may be necessary to monitor health and progress.
• Participants may receive compensation for their time and travel.

To join, you need to have a history of gout and meet certain health criteria. You should have had at least two gout attacks in the past year and weigh at least 50 kg (about 110 pounds). You cannot join if you have had cancer recently, are pregnant or breastfeeding, or have had kidney stones in the last six months.